From Health Canada:
Hoffmann-La Roche Limited, in consultation with Health Canada, has informed Canadian healthcare professionals of important new safety information concerning AVASTIN (bevacizumab).
For Health Professionals...
For the Public...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment